Related Experiment Video
Updated: Aug 14, 2025

Murine Myocardial Infarction Model using Permanent Ligation of Left Anterior Descending Coronary Artery
Published on: August 16, 2019
Toll-like receptor 9 signaling after myocardial infarction: Role of p66ShcA adaptor protein
Anton Baysa1, Azzam A Maghazachi1, Kristin Larsen Sand1
1Department of Molecular Medicine, Institute of Basic Medical Science University of Oslo, Norway.
Abstract:
During myocardial infarction, cellular debris is released, causing a sterile inflammation via pattern recognition receptors. These reactions amplify damage and promotes secondary heart failure. The pattern recognition receptor, Toll-like receptor 9 (TLR9) detects immunogenic fragments of endogenous DNA, inducing inflammation by NFκB. The p66ShcA adaptor protein plays an important role in both ischemic myocardial damage and immune responses. We hypothesized that p66ShcA adaptor protein promotes DNA-sensing signaling via the TLR9 pathway after myocardial infarction. TLR9 protein expression increased in cardiac tissue from patients with end-stage heart failure due to ischemic heart disease. Myocardial ischemia in mice in vivo induced gene expression of key TLR9 pathway proteins (MyD88 and Unc93b1). In this model, a functional link between TLR9 and p66ShcA was revealed as; (i) ischemia-induced upregulation of TLR9 protein was abrogated in myocardium of p66ShcA knockout mice; (ii) when p66ShcA was overexpressed in NFkB reporter cells stably expressing TLR9, NFkB-activation increased during stimulation with the TLR9 agonist CpG B; (iii) in cardiac fibroblasts, p66ShcA overexpression caused TLR9 upregulation. Co-immunoprecipitation showed that ShcA proteins and TLR9 may be found in the same protein complex, which was dissipated upon TLR9 stimulation in vivo. A proximity assay confirmed the co-localization of TLR9 and ShcA proteins. The systemic immune response after myocardial ischemia was dampened in p66ShcA knockout mice as interleukin-4, -17 and -22 expression in mononuclear cells isolated from spleens was reduced. In conclusion, p66ShcA adaptor may be an interaction partner and a regulator of the TLR9 pathway post-infarction.
Insights
The p66ShcA adaptor protein interacts with Toll-like receptor 9 (TLR9), amplifying inflammation after heart attack. Blocking p66ShcA reduces this immune response, offering a potential therapeutic target for myocardial infarction.
Area of Science:
- Cardiovascular Biology
- Immunology
- Molecular Medicine
Background:
- Myocardial infarction (MI) triggers sterile inflammation via pattern recognition receptors, exacerbating damage and leading to heart failure.
- Toll-like receptor 9 (TLR9) detects endogenous DNA fragments, initiating inflammatory responses mediated by NFκB.
- The p66ShcA adaptor protein is implicated in both ischemic injury and immune modulation.
Purpose of the Study:
- To investigate the role of the p66ShcA adaptor protein in regulating DNA-sensing signaling through the TLR9 pathway following myocardial infarction.
- To determine if p66ShcA influences TLR9 expression and activation in the context of cardiac ischemia.
Main Methods:
- Analysis of TLR9 protein expression in human heart failure tissue.
- Induction of myocardial ischemia in p66ShcA knockout and wild-type mice.
- Assessment of TLR9 pathway gene expression (MyD88, Unc93b1) post-ischemia.
- In vitro studies using NFκB reporter cells and cardiac fibroblasts to examine p66ShcA-TLR9 interactions.
- Co-immunoprecipitation and proximity assays to confirm protein complex formation.
- Measurement of systemic inflammatory markers (interleukins) in knockout mice.
Main Results:
- TLR9 expression was elevated in cardiac tissue from patients with ischemic heart failure.
- Myocardial ischemia in mice upregulated key TLR9 pathway components.
- p66ShcA deficiency abrogated ischemia-induced TLR9 upregulation and dampened systemic inflammation.
- Overexpression of p66ShcA enhanced TLR9-mediated NFκB activation and increased TLR9 expression in cardiac fibroblasts.
- Co-immunoprecipitation and proximity assays confirmed physical interaction between ShcA proteins and TLR9.
Conclusions:
- p66ShcA adaptor protein plays a crucial role in promoting TLR9-mediated inflammatory signaling after myocardial infarction.
- p66ShcA may act as a regulator and interaction partner of the TLR9 pathway in the post-infarction cardiac environment.
- Targeting the p66ShcA-TLR9 interaction could represent a novel therapeutic strategy to mitigate inflammation and secondary damage following MI.
Related Concept Videos
Assembly of Signaling Complexes
Interaction domains in cell signaling
Interaction domains recognize exposed features of their binding partners containing post-translationally modified sequences,...
Myocarditis I: Introduction
TGF - β Signaling Pathway
The JAK-STAT Signaling Pathway
Intracellular Signaling Affects Focal Adhesions
Some...
Hedgehog Signaling Pathway

